Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Gabapentin 800mg tablets |
| BNF code | 0408010G0AAAKAK |
| Virtual Therapeutic Moiety | Gabapentin |
| Date identifier became valid | 4 Aug 2023 |
| Previous product identifier | 323022001 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Gabapentin |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 800.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 3 (CD No Register Exempt Safe Custody) |
| Date of applicability | 1 Apr 2019 |
| Previous Controlled Drug information | No Controlled Drug Status |
| Actual Medicinal Products | |
| Gabapentin 800mg tablets (A A H Pharmaceuticals Ltd) | |
| Gabapentin 800mg tablets (Accord-UK Ltd) | |
| Gabapentin 800mg tablets (Alliance Healthcare (Distribution) Ltd) | |
| Gabapentin 800mg tablets (Brown & Burk UK Ltd) | |
| Gabapentin 800mg tablets (Glenmark Pharmaceuticals Europe Ltd) | |
| Gabapentin 800mg tablets (Medihealth (Northern) Ltd) | |
| Gabapentin 800mg tablets (Milpharm Ltd) | |
| Gabapentin 800mg tablets (Sigma Pharmaceuticals Plc) | |
| Gabapentin 800mg tablets (Strides Pharma UK Ltd) | |
| Neurontin 800mg tablets (Viatris UK Healthcare Ltd) | |
| Virtual Medicinal Product Packs | |
| Gabapentin 800mg tablets 100 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.